Triple-negative breast cancer patients treated with subcutaneous mastectomy with immediate reconstruction: single institution experience

被引:0
|
作者
Bocian, Artur [1 ]
Macek, Pawel [2 ,3 ]
Kedzierawski, Piotr [3 ,4 ]
机构
[1] Holycross Canc Ctr, Oncol Surg Clin, Kielce, Poland
[2] Holycross Canc Ctr, Sci Res Epidemiol & R&D Ctr, Kielce, Poland
[3] Jan Kochanowski Univ, Coll Medicum, Kielce, Poland
[4] Holycross Canc Ctr, Radiotherapy Clin, Artwinskiego 3, PL-25734 Kielce, Poland
来源
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY | 2024年 / 23卷 / 04期
关键词
combined treatment; triple-negative breast cancer; subcutaneous mastectomy; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; NODE BIOPSY; ADJUVANT;
D O I
10.5114/pm.2024.145951
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Triple-negative breast cancer (TNBC) accounts for approximately 15-20% of all breast carcinomas. In the last two decades, both nipple-sparing mastectomy (NSM) and skin-sparing mastectomy (SSM) with immediate reconstruction have been used in the surgical management. The aim of our study was to analyze the outcomes of the combined treatment of patients with TNBC treated with NSM or SSM. Material and methods: A total of 114 women with TNBC were enrolled in this study. All diagnostic, therapeutic and follow-up procedures were conducted in one center of the Holycross Cancer Centre in Kielce. In all patients, subcutaneous mastectomy was performed. Overall survival was estimated by the Kaplan-Meier method. The influence of selected prognostic factors on the risk of death was analyzed using the Cox proportional hazards models. Results: The probability of survival at 1, 3, and 5 years was 0.982, 0.894, 0.850, respectively. Based on the 5-factor Cox model, all included features had a significant relationship with the risk of death. In conclusion, the presence of a genetic mutation, adjuvant chemotherapy, complete pathological regression, and the absence of radiotherapy significantly reduced the risk of death. Conclusions: The results of the treatment with subcutaneous mastectomy are good. The early stage of the cancer is associated with a better prognosis. Complete pathological regression after systemic treatment, particularly in patients with BRCA1 mutation, is a good prognostic factor and can help diminish the range of surgery in the axilla region.
引用
收藏
页码:192 / 199
页数:8
相关论文
共 50 条
  • [41] Effect of surgical complications on outcomes in breast cancer patients treated with mastectomy and immediate reconstruction
    Emily L. Siegel
    Junmin Whiting
    Younchul Kim
    Weihong Sun
    Christine Laronga
    M. Catherine Lee
    Breast Cancer Research and Treatment, 2021, 188 : 641 - 648
  • [42] Effect of surgical complications on outcomes in breast cancer patients treated with mastectomy and immediate reconstruction
    Siegel, Emily L.
    Whiting, Junmin
    Kim, Younchul
    Sun, Weihong
    Laronga, Christine
    Lee, M. Catherine
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (03) : 641 - 648
  • [43] Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience
    Khalifa, Jonathan
    Duprez-Paumier, Raphaelle
    Filleron, Thomas
    Triki, Magali Lacroix
    Jouve, Eva
    Dalenc, Florence
    Massabeau, Carole
    BREAST JOURNAL, 2016, 22 (05): : 510 - 519
  • [44] Breast Conservation Therapy Achieved Comparable Outcomes with Mastectomy in Patients with T1-2N0 Triple-Negative Breast Cancer: Analysis of 822 Patients in a Single Institution
    Wang, S.
    Tang, Y.
    Fang, H.
    Sun, G.
    Jing, H.
    Song, Y. W.
    Wang, J.
    Jin, J.
    Liu, Y.
    Ren, H.
    Yu, Z.
    Li, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E594 - E594
  • [45] Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience
    Aksoy, S.
    Dizdar, O.
    Harputluoglu, H.
    Altundag, K.
    ANNALS OF ONCOLOGY, 2007, 18 (11) : 1904 - 1906
  • [46] Clinical and pathological characteristics of triple-negative breast cancer patients: A single-center experience.
    Akdeniz, Aydan
    Yalcin, Selim
    Rahatli, Samed
    Kucukoztas, Nadire
    Yagmurdur, Mahmut Can
    Dizdar, Omer
    Altundag, Ozden
    Ozyilkan, Ozgur
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis
    Perez, Carmen A.
    Zumsteg, Zachary S.
    Gupta, Gaorav
    Morrow, Monica
    Arnold, Brittany
    Patil, Sujata M.
    Traina, Tiffany A.
    Robson, Mark E.
    Wen, Yong H.
    McCormick, Beryl
    Powell, Simon N.
    Ho, Alice Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 497 - 506
  • [48] Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience
    Asleh-Aburaya, Karama
    Fried, Georgeta
    SPRINGERPLUS, 2015, 4 : 1 - 7
  • [49] Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis
    Carmen A. Perez
    Zachary S. Zumsteg
    Gaorav Gupta
    Monica Morrow
    Brittany Arnold
    Sujata M. Patil
    Tiffany A. Traina
    Mark E. Robson
    Yong H. Wen
    Beryl McCormick
    Simon N. Powell
    Alice Y. Ho
    Breast Cancer Research and Treatment, 2013, 139 : 497 - 506
  • [50] Outcomes of patients with triple-negative breast cancer treated with nodiation therapy.
    Yadav, Siddhartha
    Jawad, Maha Saada
    Wobb, Jessica
    Ben Wilkinson, J.
    Yadav, Dhiraj
    Wallace, Michelle
    Barnes, Michael A.
    Grills, Inga S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)